New Data From Gilead On Covid-19 Drug Raises Hope
Publisher |
Barron's
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Apr 14, 2020
Episode Duration |
00:04:06
The meat producer Smithsfield closes a plant because of coronavirus. SoftBank expects nearly $17 billion loss on tech-focused Vision Fund. And new data on Gilead Sciences Covid-19 drug is promising but inconclusive. Hosted by Jacob Passy/Marketwatch. Produced by Mette Lützhøft and Katie Ferguson.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review